Self-evolving persistent luminescence nanoprobes for autofluorescence-free ratiometric imaging and on-demand enhanced chemodynamic therapy of pulmonary metastatic tumors-Reference-Cited by-同舟云学术

Self-evolving persistent luminescence nanoprobes for autofluorescence-free ratiometric imaging and on-demand enhanced chemodynamic therapy of pulmonary metastatic tumors

Published:2024 Issue:12 Volume:12 Page:3229-3237
ISSN:2047-4830
Container-title:Biomaterials Science
language:en
Short-container-title:Biomater. Sci.

Author:

Zhao Xu¹²³^ORCID,Gu Tian-Yue¹²³,Xia You-Peng¹²³,Gao Xue-Mei⁴,Chen Li-Jian¹²³^ORCID,Yan Li-Xia¹²³^ORCID,Yan Xiu-Ping¹²³⁴^ORCID

Affiliation:

1. State Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi 214122, China

2. International Joint Laboratory on Food Safety, Jiangnan University, Wuxi 214122, China

3. Institute of Analytical Food Safety, School of Food Science and Technology, Jiangnan University, Wuxi 214122, China

4. Key Laboratory of Synthetic and Biological Colloids, Ministry of Education, School of Chemical and Material Engineering, Jiangnan University, Wuxi, 214122, China

Abstract

A self-evolving persistent luminescence nanoprobe ZGMC@ZGC-TAT was constructed for autofluorescence-free ratiometric imaging and on-demand enhanced chemodynamic therapy for the diagnosis and treatment of pulmonary metastatic tumors.

Funder

Natural Science Foundation of Jiangsu Province

Collaborative Innovationcenter of Food Safety and Quality Control in Jiangsu Province

National Natural Science Foundation of China

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/BM/D4BM00379A

Reference37 articles.

1. CXCR4‐Enriched Nano‐Trap Targeting CXCL12 in Lung for Early Prevention and Enhanced Photodynamic Therapy of Breast Cancer Metastasis

2. “Cluster Bomb” Based Bismuth Nano‐in‐Micro Spheres Formed Dry Powder Inhalation for Thermo‐Radio Sensitization Effects of Lung Metastatic Breast Cancer

3. Defining the Hallmarks of Metastasis

4. Diagnosis of oligometastasis

5. The landscape of metastatic progression patterns across major human cancers